Home Elpiscience Biopharmaceuticals Files for HKEX IPO with Clinical-Stage Oncology Pipeline Targeting 'Cold' Tumors

Elpiscience Biopharmaceuticals Files for HKEX IPO with Clinical-Stage Oncology Pipeline Targeting 'Cold' Tumors

CST Updated May 28, 2026 09:59